OSR Health OSRH
OTC OSRH
$0.19 -0.01 (-5.00%)
At close: Oct 15, 2026 · 4:00 PM EDT

OSR Health (OSRH) EBITDA (2024 - 2026)

Updated

OSR Health (OSRH) posted EBITDA of -$669,973 for Q2 2026, compared with -$2.88 million a year earlier.

Analysis

OSR Health (OSRH) EBITDA (2024 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBITDA at OSR Health was -$7.42 million; for FY2025, it came in at -$9.03 million.

  • In prior years, OSR Health's EBITDA was -$2 million in FY2024.
  • The Q2 2026 figure stands as the highest quarterly EBITDA since Q1 2025.
  • According to Business Quant data, EBITDA for the three prior quarters was -$1.24 million (Q1 2026), -$4.09 million (Q4 2025) and -$1.42 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Eli Lilly 1,157.23 Bn 1,125.82 Bn 19.71 Bn 12.29 Bn
2 Johnson & Johnson 625.90 Bn 544.43 Bn 17.26 Bn 9.10 Bn
3 AbbVie 509.60 Bn 482.71 Bn 12.70 Bn 8.33 Bn
4 Merck 365.39 Bn 319.77 Bn 12.21 Bn 999.00 Mn
5 Novartis Ag 296.36 Bn 260.35 Bn 11.24 Bn -
6 Astrazeneca 261.03 Bn 234.71 Bn 12.86 Bn 5.09 Bn
7 Amgen 235.15 Bn 190.55 Bn 7.24 Bn 4.63 Bn
8 Gilead Sciences 193.31 Bn 167.51 Bn 6.22 Bn -9.70 Bn
9 Pfizer 170.88 Bn 117.53 Bn 10.94 Bn 5.89 Bn
10 OSR Health 6.41 Mn -1.26 Mn 86,605.00 -669,973.17
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -669,973.17
Mar 31, 2026 -1.24 Mn
Dec 31, 2025 -4.09 Mn
Sep 30, 2025 -1.42 Mn
Jun 30, 2025 -2.88 Mn
Mar 31, 2025 -644,631.29
Dec 31, 2024 -459,387.00
Sep 30, 2024 -736,132.00
Jun 30, 2024 -417,286.00
Mar 31, 2024 -389,418.00
API Access

OSR Health EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=OSRH&period=max&api_key=YOUR_API_KEY